Acarbose capsules

It is a new type of oral hypoglycemic drug that competitively inhibits glucosidase in the intestine, reduces the decomposition of polysaccharides and sucrose to produce glucose, reduces and delays absorption, and thus has the effect of reducing postprandial hyperglycemia and plasma insulin concentration.

Acarbose.

This product is in the form of capsules.

It can be used for insulin-dependent or non-insulin-dependent diabetes, and can also be used in combination with other oral hypoglycemic drugs or insulin.

The oral dosage needs to be individualized, generally 50 to 200 mg/time, 3 times/day, taken before meals.

It can cause intestinal gas, abdominal distension, abdominal pain, diarrhea, etc., and some individuals may also experience hypoglycemia.

It is contraindicated for patients who are allergic to acarbose, patients under 18 years of age, pregnant and lactating women, patients with chronic functional disorders with obvious digestive or absorption disorders, and conditions that may be worsened by intestinal flatulence (such as Roemheid's syndrome, severe hernia, intestinal obstruction and intestinal ulcer).

Precautions for children: Since there is no sufficient data on the efficacy and tolerance of this product for children and adolescents, this product should not be used in patients under 18 years old. Precautions for pregnancy and lactation: 1. Because there is no data on the use of this drug in pregnant women, pregnant women are prohibited from using it. 2. After lactating rats took radiolabeled acarbose, a small amount of radioactive substances was found in their milk, and no similar findings have been found in humans. Even so, since the effect of acarbose in breast milk on infants cannot be ruled out, it is prohibited for lactating women. Precautions for the elderly: No special precautions.

1. When using high doses, asymptomatic elevation of liver enzymes may occur in individual cases, so monitoring of liver enzyme changes should be considered in the first 6 to 12 months of treatment. 2. When this product is used in combination with sulfonylureas, metformin or insulin, if the blood sugar concentration drops to the hypoglycemia range, the dose of sulfonylureas, metformin or insulin should be appropriately reduced; if acute hypoglycemia occurs, it should be considered that this product inhibits the decomposition of sucrose. For this reason, sucrose is not suitable for rapid relief of hypoglycemia symptoms, and glucose should be used instead. 3. Avoid taking it at the same time with antacids, cholestyramine, intestinal adsorbents and digestive enzyme products, as they may reduce the effect of this product.

Keep away from light and store in a sealed container.

50mg

Tentative 24 months